NASDAQ:LMNL
Liminal BioSciences Inc.
- Stock
locale
Canadamarket
STOCKSindustry
Biotechnologywebsite
www.liminalbiosciences.comipo date
Dec 18, 2009
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, li...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus